Google had a pretty good day in the market today, with GOOG shares rising quite a bit to close at $402.13, a semi-meteoric rise of $14.96 per share or 3.86%. Whoa -- what happened to cause the runup? Beats me -- there were no earth-shattering announcements today, right? Except for this little nugget about a CPA advertising ValueClick-killer about to be unleased by our Google friends. Make no mistake about it, folks, Google appears to be in the midst of launching a cost-per-action advertising affiliate network that'll probably be unrivaled in reach, anywhere.
On the other hand, while it's interesting to see that Google's ultra-famous search result customer relevancy is seemingly controlled by an expert (or a small group of experts?), it's incredibly hard to believe that search relevancy is not controlled by a globally-centralized and connected team of artificial intelligence experts more than anyone.
There are about as many questions for Google to answer in order for its unsightly market valuation to be justified -- and the laundry list is pretty meaty. As a GOOG investor, what are your thoughts? Is the rapid-fire pace of Google product launches and the media attention on Google being some sort of "Microsoft-killer" enough to make you scream to the hills? Are all these new Google services really adding value to the customer marketplace, and what are the specific ways Google plans on monetizing these services?
Google has so many things working right for them at the moment, but they have just as many looming scenarios and questions to deal with that perhaps a collision is about to take place and a correction with GOOG is looming somewhere on the horizon. What do you think?
Last updated: February 10, 2012: 03:53 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- Rackspace February calls active into Q4 and outlook
- Moody's management to meet with Lazard Capital
- Dell volatility at low end of range into Q4 results and revenue outlook
- Watson sued by Bayer over birth control patent, Bloomberg reports
- Green Mountain Coffee March volatility at five-month lows
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?

